Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway

Resibufogenin (RBF), an active compound from Bufo bufonis, has been used for the treatment of multiple malignant cancers, including pancreatic cancer, colorectal cancer, and breast cancer. However, whether RBF could exert its antitumor effect by inhibiting angiogenesis remains unknown. Here, we aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ting, Jiang, Yi-Xin, Wu, Ye, Lu, Dong, Huang, Rui, Wang, Long-Ling, Wang, Shi-Qi, Guan, Ying-Yun, Zhang, Hong, Luan, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121540/
https://www.ncbi.nlm.nih.gov/pubmed/33995111
http://dx.doi.org/10.3389/fphar.2021.682735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121540/
https://www.ncbi.nlm.nih.gov/pubmed/33995111
http://dx.doi.org/10.3389/fphar.2021.682735

Ejemplares similares